February 27, 2023

Recent Study Co-authored by Veranex Staff Highlights Cost-effectiveness of Home Non-invasive Ventilation in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom

February 27, 2023

January 18, 2023

Demonstrating Clinical Utility Using a Validated Methodology From the Market Research Toolkit

January 18, 2023

January 4, 2023

Real-World Time and Motion Study by Veranex and Alcon Demonstrates Enhanced Practice Efficiencies and Time Savings for Cataract Evaluation and Surgery

January 4, 2023

September 7, 2022

Veranex Supports Philips Healthcare with Writing Manuscript of Medicare Claims Study of Mobile Cardiac Monitoring

September 7, 2022

August 2, 2022

Study by Veranex and Proteomics International Demonstrates Clinical Utility of Prognostic Test for Type 2 Diabetes Patients

August 2, 2022

June 21, 2022

Published Health Economics Study Shows a High Disease Burden Associated with Stress/Mixed Urinary Incontinence to U.S. Payers

June 21, 2022

May 6, 2022

U.S. Market Access and Commercialization Planning for Novel Genomic Test

Veranex_BHA_Overview_CS-Graphics_4-14-22_VF_Advanced-Diagnostics-02-1

May 6, 2022

April 8, 2022

Study by Veranex and Thermo Fisher Highlights Payer Budget Impact of Novel Test for Kidney Transplant Rejection

April 8, 2022

April 1, 2022

Dasiglucagon Demonstrates Reduced Costs in the Treatment of Severe Hypoglycemia in a Budget Impact Model

April 1, 2022

April 1, 2022

Veranex Supports Retrospective Claims Analysis of Physical Therapy Utilization Among Women With Stress or Mixed Urinary Incontinence

April 1, 2022